iOmx Therapeutics is a clinical-stage biotech company that harnesses deep tumor immunology insights to generate novel treatments for the most prevalent solid tumor indications
iOmx Therapeutics is a clinical-stage biotech company that harnesses deep tumor immunology insights to generate novel treatments for the most prevalent solid tumor indications. The company is translating unexplored immune evasion biology into a growing pipeline of biomarker-enabled drug programs.